Theralase Technologies Inc
XTSX:TLT
Theralase Technologies Inc
XTSX:TLT
Price:
0.165 CAD
3.13%
Market Closed
Updated:
May 7, 2024
Theralase Technologies Inc
Cash from Operating Activities
|
Theralase Technologies Inc
Cash from Operating Activities Peer Comparison
Comparables:
NVCN
PRN
OPS
NSCI
MIR
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Theralase Technologies Inc
XTSX:TLT
|
Cash from Operating Activities
-CA$4.1m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-16%
|
|
|
Neovasc Inc
TSX:NVCN
|
Cash from Operating Activities
-$24.9m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
29%
|
CAGR 10-Years
-28%
|
|
|
Profound Medical Corp
TSX:PRN
|
Cash from Operating Activities
-$22.3m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Opsens Inc
TSX:OPS
|
Cash from Operating Activities
-CA$14.5m
|
CAGR 3-Years
-144%
|
CAGR 5-Years
-69%
|
CAGR 10-Years
-46%
|
|
|
Nanalysis Scientific Corp
XTSX:NSCI
|
Cash from Operating Activities
-CA$8.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
MedMira Inc
XTSX:MIR
|
Cash from Operating Activities
-CA$2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-20%
|
CAGR 10-Years
4%
|
See Also
What is Theralase Technologies Inc's Cash from Operating Activities?
Cash from Operating Activities
-4.1m
CAD
-4.1m
CAD
Based on the financial report for Dec 31, 2023, Theralase Technologies Inc's Cash from Operating Activities amounts to -4.1m CAD.
What is Theralase Technologies Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-16%
-16%
Over the last year, the Cash from Operating Activities growth was 21%. The average annual Cash from Operating Activities growth rates for Theralase Technologies Inc have been 3% over the past three years , -27% over the past five years , and -16% over the past ten years .
You don't have any saved screeners yet
